BioCentury | Apr 4, 2017
Distillery Techniques

Imaging

...online March 13, 2017 doi:10.1038/s41551-017-0040 CONTACT: Le Qiu, Harvard University, Boston, Mass. email: lqiu@caregroup.harvard.edu CONTACT: Lev...
BioCentury | Aug 14, 2014
Cover Story

Navigating the new road in psychiatry

...system disorders: workshop summary . (The National Academies Press, 2013) C. Simone Fishburn, Executive Editor, and Lev...
BioCentury | Aug 7, 2014
Tools & Techniques

High throughput remyelination

...human diseases including MS. The technology is available for licensing. -K-JL & LZO Kai-Jye Lou and Lev...
BioCentury | Jul 17, 2014
Targets & Mechanisms

Hedgehog joins the resistance

...Montreal, Montreal, Quebec, Canada e-mail: katherine.borden@umontreal.ca 2. Zhao, C. et al. Nature 458 , 776-779 (2009) Lev...
BioCentury | Jul 10, 2014
Targets & Mechanisms

Priming the PD pump

...62 , 218-229 (2009) 5. Hu, G. et al. ACS Chem. Biol. 8 , 1947-1954 (2013) Lev...
BioCentury | Jun 30, 2014
Emerging Company Profile

Inception 5: Myelin layer

...Number of employees: Undisclosed Funds raised: Undisclosed Investors: Versant Ventures CEO: Peppi Prasit Patents: None issued Lev...
BioCentury | Jun 19, 2014
Translation in Brief

Translational tidbits

...and expertise that could help identify and advance development of potential therapies for inherited retinal diseases Lev...
BioCentury | Jun 12, 2014
Targets & Mechanisms

Putting SMYD3 on the MAP

...e ), leaving the kinase stuck in an active state to promote hyperactive proliferative signaling. Lev...
BioCentury | Jun 9, 2014
Emerging Company Profile

Glactone: ProSTATe stopper

...Investors: Partners for Development Investments in Life Sciences AB (PULS) CEO: Martin Johansson Patents: None issued Lev...
BioCentury | May 22, 2014
Translation in Brief

Translational tidbits

...Organization Infectious disease Undisclosed Develop Sabin inactivated polio vaccine under the public-private Global Polio Eradication Initiative Lev...
Items per page:
1 - 10 of 374
BioCentury | Apr 4, 2017
Distillery Techniques

Imaging

...online March 13, 2017 doi:10.1038/s41551-017-0040 CONTACT: Le Qiu, Harvard University, Boston, Mass. email: lqiu@caregroup.harvard.edu CONTACT: Lev...
BioCentury | Aug 14, 2014
Cover Story

Navigating the new road in psychiatry

...system disorders: workshop summary . (The National Academies Press, 2013) C. Simone Fishburn, Executive Editor, and Lev...
BioCentury | Aug 7, 2014
Tools & Techniques

High throughput remyelination

...human diseases including MS. The technology is available for licensing. -K-JL & LZO Kai-Jye Lou and Lev...
BioCentury | Jul 17, 2014
Targets & Mechanisms

Hedgehog joins the resistance

...Montreal, Montreal, Quebec, Canada e-mail: katherine.borden@umontreal.ca 2. Zhao, C. et al. Nature 458 , 776-779 (2009) Lev...
BioCentury | Jul 10, 2014
Targets & Mechanisms

Priming the PD pump

...62 , 218-229 (2009) 5. Hu, G. et al. ACS Chem. Biol. 8 , 1947-1954 (2013) Lev...
BioCentury | Jun 30, 2014
Emerging Company Profile

Inception 5: Myelin layer

...Number of employees: Undisclosed Funds raised: Undisclosed Investors: Versant Ventures CEO: Peppi Prasit Patents: None issued Lev...
BioCentury | Jun 19, 2014
Translation in Brief

Translational tidbits

...and expertise that could help identify and advance development of potential therapies for inherited retinal diseases Lev...
BioCentury | Jun 12, 2014
Targets & Mechanisms

Putting SMYD3 on the MAP

...e ), leaving the kinase stuck in an active state to promote hyperactive proliferative signaling. Lev...
BioCentury | Jun 9, 2014
Emerging Company Profile

Glactone: ProSTATe stopper

...Investors: Partners for Development Investments in Life Sciences AB (PULS) CEO: Martin Johansson Patents: None issued Lev...
BioCentury | May 22, 2014
Translation in Brief

Translational tidbits

...Organization Infectious disease Undisclosed Develop Sabin inactivated polio vaccine under the public-private Global Polio Eradication Initiative Lev...
Items per page:
1 - 10 of 374